Home
Knowledge Hub: e-learning materials
General Annual Meeting (GAM)
Satellite 3: Pfizer | T-Cell Redirecting Therapies in RRMM: Bridging Clinical Trials and Real-World Outcomes
Satellite 3: Pfizer | T-Cell Redirecting Therapies in RRMM: Bridging Clinical Trials and Real-World Outcomes
In short
Information sheet
Published
08 Feb 2025
Presenter
Gordon Cook, Roberto Mina & Michel Delforge
Chairs
Michel Delforge
Member login required
This content is part of our learning materials for our members. Login or see our membership information